Skip to main content

Find Clinical Trials

Home
Conditions
Locally Advanced or Metastatic Renal Cell Carcinoma

Clinical trial condition

Locally Advanced or Metastatic Renal Cell Carcinoma

Explore clinical trials studying Locally Advanced or Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Renal Cell Carcinoma trial results

Not Yet Recruiting

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

NCT07470840

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

View Trial Details

Completed

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

NCT03945773

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: SALK - Salzburger Landesklinik Salzburg, Austria

CHRU Besançon Besançon, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Léon Bérard Lyon, France

View all 40 locations

View Trial Details

Completed

Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors

NCT04353765

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: McKesson Life Sciences The Woodlands, Texas, United States

View Trial Details